YAP1 and sarcoma: In addition to their tumor promoting capabilities, the Hippo pathway end effectors TAZ and YAP have also been shown to have the capacity to drive metastasis in a broad spectrum of cancers such as breast, melanoma, lung, gastric, and colorectal, as well as sarcomas [42].